HLB bioStep Inside Director Jin Yang-gon Reports Decrease in Shares Due to Stock Consolidation and Open Market Purchase, Ownership Percentage Slightly Increases


  • HLB bioStep inside director Jin Yang-gon filed a report on ownership of specific securities as of June 10, 2026.
  • Due to a stock consolidation, his holdings decreased from 733,492 shares to 146,706 shares, then he purchased 25,000 shares via open market, resulting in a total of 171,706 shares.
  • His ownership percentage increased slightly from 0.84% to 0.98%.
  • This is a personal transaction and unrelated to any capital changes or fundraising by the company.
  • [AI Summary]The share change by inside director Jin Yang-gon is a routine adjustment due to stock consolidation and a small open market purchase, with limited direct impact on the market.

KOSDAQ Filing Information


  • Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: HLB bioStep (278650)
  • Submission: Jin Yang-gon

  • Shares: 17,432,396
  • Price: 2,975 KRW
  • Market Cap: 51.9 B KRW